Selective dose escalation of chemoradiotherapy for esophageal cancer: Role of treatment intensification

Seminars in Oncology

Volumn 31, Issue SUPPL. 18, 2004, Pages 13-19

  Seung, Steven K ^a   Smith II, John W ^b   Molendyk, John ^a   Bader, Stephen B ^a   Phillips, Michael ^a   Regan, James ^a   Louie, Jeannie ^a   Soo, Edward ^b   Seligman, Mark ^c   Ruzich, Janet ^c   Skokan, Laurie ^d   Ross, Helen J ^a,e  

^a Oregon Clinic   (United States)

^b Oregon Hematol Oncology Associates ^*

^c Oregon Hematol Oncology Associates   (United States)

^d PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

^e EARLE A CHILES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ASPIRATION PNEUMONIA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DOSE CALCULATION; DRUG CYTOTOXICITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG INFUSION; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS METASTASIS; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STOMATITIS; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 13844289420     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.12.006     Document Type: Conference Paper

References (29)

1. R.T. Greenlee, M.B. Hill-Harmon, T. Murray Cancer statistics, 2001 CA Cancer J Clin 51 2001 15 36
2. W.J. Blot, S.S. Devesa, J.F. Fraumeni Jr Continuing climb in rates of esophageal adenocarcinoma An update JAMA 270 1993 1320
3. P.J. Hesketh, R.W. Clapp, W.G. Doos The increasing frequency of adenocarcinoma of the esophagus Cancer 64 1989 526 530
4. S.S. Devesa, W.J. Blot, J.F. Fraumeni Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 1998 2049 2053
5. A.A. Forastiere, M.B. Orringer, C. Perez-Tamayo Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus Final report J Clin Oncol 11 1993 1118 1123
6. L. Leichman, Z. Steiger, H.G. Seydel Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus A potentially curative approach J Clin Oncol 2 1984 75 79
7. E. Poplin, T. Fleming, L. Leichman Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037) J Clin Oncol 5 1987 622 628
8. A.A. Meluch, F.A. Greco, J.R. Gray Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer Final results of a Minnie Pearl Cancer Research Network phase II trial Cancer J 9 2003 251 260
9. S.G. Urba, M.B. Orringer, A. Turrisi Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313
10. T.N. Walsh, N. Noonan, D. Hollywood A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467 [Erratum appears in N Engl J Med 341:384, 1999]
11. E. Le Prise, P.L. Etienne, B. Meunier A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer 73 1994 1779 1784
12. J.F. Bosset, M. Gignoux, J.P. Triboulet Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 1997 161 167
13. J.S. Cooper, M.D. Guo, A. Herskovic Radiation Therapy Oncology Group Chemoradiotherapy of locally advanced esophageal cancer Long-term follow-up of a prospective randomized trial (RTOG 85-01) JAMA 281 1999 1623 1627
14. B.D. Minsky, T.F. Pajak, R.J. Ginsberg INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
15. A.A. Meluch, J.D. Hainsworth, J.R. Gray Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer Preliminary results of a Minnie Pearl Cancer Research Network phase II trial Cancer J Sci Am 5 1999 84 91
16. A.H. Calvert, D.R. Newell, L.A. Gumbrell Carboplatin dosage Prospective evaluation of a simple formula based on renal function J Clin Oncol 7 1989 1748 1756
17. E.L. Kaplan, P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
18. C.M. Araujo, L. Souhami, R.A. Gil A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus Cancer 67 1991 2258 2261
19. T.J. Smith, L.M. Ryan, H.O. Douglass Jr Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus A study of the Eastern Cooperative Oncology Group Int J Radiat Oncol Biol Phys 42 1998 269 276
20. A. Herskovic, K. Martz, M. al-Sarraf Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1992 1593 1598
21. A. Roussel, J.H. Jacob, P. Haegele Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma A study of the EORTC Gastrointestinal Tract Cancer Cooperative Group Recent Results Cancer Res 110 1988 21 29
22. B.D. Beseth, R. Bedford, W.H. Isacoff Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy Am Surg 66 2000 827 831
23. C.R. Thomas Jr., B.A. Berkey, B.D. Minsky Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials Int J Radiat Oncol Biol Phys 58 2004 1405 1410
24. A.E. Korst, C.M. Eeltink, J.B. Vermorken Pharmacokinetics of amifostine and its metabolites in patients Eur J Cancer 33 1997 1425 1429
25. J.M. Yuhas Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine Cancer Treat Rep 63 1979 971 976
26. D. Antonadou, A. Petridis, M. Synodinou Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer Semin Oncol 30 2003 2 9
27. R. Komaki, J.S. Lee, L. Milas Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer Report of a randomized comparative trial Int J Radiat Oncol Biol Phys 58 2004 1369 1377
28. M.I. Koukourakis, G. Kyrias, S. Kakolyris Subcutaneous administration of amifostine during fractionated radiotherapy A randomized phase II study J Clin Oncol 18 2000 2226 2233
29. M.I. Koukourakis, C. Simopoulos, G. Minopoulos Amifostine before chemotherapy Improved tolerance profile of the subcutaneous over the intravenous route Clin Cancer Res 9 2003 3288 3293